Methylation Patterns of Rb1 and Casp-8 Promoters and Their Impact on Their Expression in Bladder Cancer

REFERENCES

• Mitra A. P., Datar R. H., Cote R. J. Molecular Pathways in Invasive Bladder Cancer: New Insights into Mechanisms, Progression, and Target Identification. J Clin Oncol 2006; 24: 5552–5564
   PubMed Web of Science ®Google Scholar
• Bladder Cancer. Cancer Research UK website, Available at: http://info.cancerresearchuk.org/cancerstats/types/bladder/?a=5441. Accessed, 2007
   Google Scholar
• Herman J. G., Graff J. R., Myohanen S., Nelkin B. D., Baylin S. B. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands (DNA methylation/tumor suppressor genes/pl6/p15). Proc. Natl. Acad. Sci. USA 1996; 93: 9821–9826
   PubMed Web of Science ®Google Scholar
• Eads C. A., Lord R. V., Wickramasinghe K., Long T. I., Kurumboor S. K., Bernstein L., et al. Epigenetic Patterns in the Progression of Esophageal Adenocarcinoma. Cancer Res. 2001; 61: 3410–3418
   PubMed Web of Science ®Google Scholar
• Kopelovich L., Crowell J. A., Fay J. R. The Epigenome as a Target for Cancer Chemoprevention. J. Nat. Cancer Inst. 2003; 95
   PubMed Web of Science ®Google Scholar
• Costello J. F., Plass C. Methylation matters. J Med Genet 2001; 38: 285–293
   PubMed Web of Science ®Google Scholar
• Baylin S. B., Herman J. G. DNA hypermethylation in tumorigenesis: Epigenetics joins genetics. Trends Genet. 2000; 16: 168–174
   PubMed Web of Science ®Google Scholar
• Hui-Juan Yang H.J., Vincent W. S., Liu V. W., Wang Y., Tsang P CK, Hextan Y. S., Ngan H. Y.S., Differential D NA. methylation profiles in gynecological cancers and correlation with clinico-pathological data. BMC Cancer 2006; 6: 212–217
   PubMedGoogle Scholar
• Costello J. F., Plass C. Methylation matters. J Med Genet 2001; 38: 285–303
   PubMed Web of Science ®Google Scholar
• Clark S. J., Melki J. DNA methylation and gene silencing in cancer: Which is the guilty party?. Oncogene 2002; 21: 5380–5387
   PubMed Web of Science ®Google Scholar
• Das P. M., Singal R. DNA Methylation and Cancer. J Clin Oncol 2004; 22: 4632–4642
   PubMed Web of Science ®Google Scholar
• Catto J WF, Azzouzi A.-R., Rehman I., et al. Promoter hypermethylation is associated with tumor location, stage, and subsequent progression in transitional cell carcinoma. J Clin Oncol 2005; 23: 2903–2910
   PubMed Web of Science ®Google Scholar
• Esteller M., Corn P. G., Baylin S. B., Herman J. G. A Gene Hypermethylation Profile of Human Cancer. Cancer Research 2001; 61: 3225–3229
   PubMed Web of Science ®Google Scholar
• Costello J. F., Fruhwald M. C., Smiraglia D. J., Rush L. J., Robertson G. P., Gao X., Wright F. A., et al. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet 2000; 24: 132–138
   PubMed Web of Science ®Google Scholar
• Stirzaker C., Millar D. S., Paul C. L., Warnecke P. M., Harrison J., Vincent P. C., Frommer M., Clark S. J., Extensive D NA. methylation spanning the Rb promoter in retinoblastoma tumors. Cancer Res 1997; 57: 2229–37
   PubMed Web of Science ®Google Scholar
• Fung Y KT, Murphree A. L., Taug A., Qian J., Hinrichs S. H., Benedict W. F. Structural evidence for the authetictity of the human retinoblastom gene. Science 1987; 236: 1657–1661
   PubMed Web of Science ®Google Scholar
• Jung I., Messing E. Molecular Mechanisms and Pathways in Bladder Cancer Development and Progression. Cancer Control 2000; 7: 325–334
   PubMedGoogle Scholar
• Doerfler W., Bohm P. DNA methylation Basic Mechanisms. Part IV: Establishment and Maintenance of DNA methylation pattern in Mammals. Springer, Berlin, Heidelberg, New York 2006; 179–201
   Google Scholar
• Shivapurkar N., Reddy J., Matta H., Sathyanarayana U. G., Huang C., Toyooka S., Minna J. D., Chaudhary P. M., Gazdar A. F. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification. Oncogene 2002; 21: 8510–8514
   PubMed Web of Science ®Google Scholar
• Lawe A. Apoptosis—an introduction. BioEssays 2003; 25: 888–896
   PubMed Web of Science ®Google Scholar
• Kischkel F. C., Kioschis P., Weitz S., Poustka A., Lichter P., Krammer P. H. Assignment of CASP8 to human chromosome band 2q33-q34 and Casp8 to the murine syntenic region on chromosome 1B-proximal C by in situ hybridization. Cytogenet Cell Genet 1998; 82: 95–96
   PubMedGoogle Scholar
• Hadano S., Yanagisawa Y., Skaug J., Fichter K., Nasir J., Martindale D., Koop B. F., et al. Cloning and characterization of three novel genes, ALS2CR1, ALS2CR2, and ALS2CR3, in the juvenile amyotrophic lateral sclerosis (ALS2) critical region at chromosome 2q33-q34: candidate genes for ALS2. Genomics 2001; 71: 200–213
   PubMed Web of Science ®Google Scholar
• Salmena L., Lemmers B., Hakem A., Matysiak-Zablocki E., Murakami K., Billie A., et al. Essential role for caspase 8 in T-cell mediated homeostasis and T-cell mediated immunity. Genes Dev 2003; 17: 883–895
   PubMed Web of Science ®Google Scholar
• Loss Of Caspase-8 Makes Neuroblastoma More Aggressive. 2006, News Release issued by St. Jude Children's Research Hospital, January 7
   Google Scholar
• Rose B. A., Crabtree J. S., Khan A. S. DNA isolation and sequencing. Essential techniques series. John Wiley & Sons, New York 1996
   Google Scholar
• Gonzalez-Gomez P., Bello M. J., Arjona D., Alonso M. E., Lomas J., DeCampos J.D., et al. Aberrant CpG island methylation in neurofibromas and neurofibrosarcomas. Oncology Reports 2003; 10: 1519–1523
   PubMed Web of Science ®Google Scholar
• Singal R., Ferdinand L., Reis I. M., Schlesselman J. J. Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. Oncology Reports 2004; 12: 631–637
   PubMed Web of Science ®Google Scholar
• Sauerbrey A., Stammler G., Zintl F., Volm M. Expression and prognostic value of the retinoblastoma tumor suppressor gene (Rb1) in childhood acute lymphoblastic leukaemia. Br. J. Haematology 1996; 94: 99–104
   PubMed Web of Science ®Google Scholar
• Lázcoz P., Muñoz J., Nistal M., Pestaña A., Encío I., Castresana J S. Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma. BMC Cancer 2006; 6: 254–259
   PubMedGoogle Scholar
• Mishina D., Katsel P., Brown S. T., Gilberts ECAM, Greenstein R. J. On the etiology of Cohn disease. Proc. Natl. Acad. Sci. USA 1996; 93: 9816–9820
   PubMed Web of Science ®Google Scholar
• Chan M. W.Y, Lun W., Chan L. W., Tang N LS, Tong J HM, et al. Hypermethylation of Multiple Genes in Tumor Tissues and Voided Urine in Urinary Bladder Cancer Patients. Clin. Cancer Res 2002; 8: 464–470
   PubMed Web of Science ®Google Scholar
• IARC. GLOBOCAN. Cancer Incidence, Mortality and Prevalence Worldwide (2002 estimates). 2002, Accessed 2005
   Google Scholar
• Devito V. T., Hellman J. S., Rossenberg S. V. Cancer-Principles and practice of Oncology. Lippincott-Williams, Philadelphia 1999; 1303–1304
   Google Scholar
• Yang X., Yan L., Davidson N. E. DNA methylation in breast cancer. EndocrRelat Cancer 2001; 8: 115–127
   PubMed Web of Science ®Google Scholar
• Jones P.A, Baylin S. B. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 2002; 3: 415–428
   PubMed Web of Science ®Google Scholar
• Murao K., Kubo Y., Ohtani N., Hara E, Arase S. Epigenetic abnormalities in coetaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways. Br J Derm 2006; 155: 999–1005
   PubMed Web of Science ®Google Scholar
• Ohtani-Fujita N., Fujita T., Aoike A., Osifchin N. E., Robbins P. D., Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor suppressor gene. Oncogene 1993; 8: 1063–1067
   PubMed Web of Science ®Google Scholar
• Cote R. J., Dunn M. D., Chatterjee S. J., Stein J. P., et al. Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53. Cancer Res 1998; 58: 1090–1094
   PubMed Web of Science ®Google Scholar
• McCabe M T., Davis J N., Day M. L. Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway. Cancer Res 2005; 65: 3624–3632
   PubMedGoogle Scholar
• Baylin S B., Herman J G., Graff J R., Vertino P M., Issa J.-P. J. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res 1998; 72: 141–156
   PubMed Web of Science ®Google Scholar
• Jones P. A., Laird P. W. Cancer epigenetics comes of age. Nat Genet 1999; 21: 163–167
   PubMed Web of Science ®Google Scholar
• Greger V., Passarge E., Hopping W., Messmer E., Horsthemke B. Epigenetic changes may ontribute to the formation and spontaneous regression of retinoblastoma. Hum Genet 1989; 83: 155–158
   PubMed Web of Science ®Google Scholar
• Sakai T., Toguchida J., Ohtani N., et al. Allele-specific hypermethylation of the retinoblastoma tumor-suppressor gene. Am J Hum Genet 1991; 48: 880–888
   PubMed Web of Science ®Google Scholar
• Merlo A., Herman J.G., Mao L., et al. 5'-CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat Med 1995; 1: 686–692
   PubMed Web of Science ®Google Scholar